EMAIL THIS PAGE TO A FRIEND

Expert review of anti-infective therapy

Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.


PMID 23566148

Abstract

Carbapenem-resistant Acinetobacter baumannii pose a significant threat to hospitalized patients, as therapeutic options are scarse. Alarmingly, rates of carbapenem-resistance in A. baumannii are on the rise and are slowly becoming a routine phenotype for this organism. This review focuses on infection control strategies for identification and control of A. baumannii, as well the available therapeutic options.